Suppr超能文献

自身免疫性胰腺炎患者的甲状腺功能减退症。

Hypothyroidism in patients with autoimmune pancreatitis.

作者信息

Shimizuguchi Ryoko, Kamisawa Terumi, Endo Yuka, Kikuyama Masataka, Kuruma Sawako, Chiba Kazuro, Tabata Taku, Koizumi Satomi

机构信息

Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan.

出版信息

World J Gastrointest Pharmacol Ther. 2018 May 6;9(2):16-21. doi: 10.4292/wjgpt.v9.i2.16.

Abstract

AIM

To examine thyroid function and clinical features of hypothyroidism in autoimmune pancreatitis (AIP) patients.

METHODS

We examined thyroid function in 77 patients with type 1 AIP (50 males, 27 females; median age 68 years, range 33-85) diagnosed according to the Japanese diagnostic criteria for AIP 2011. We compared clinical and serological findings between patients with and without various categories of hypothyroidism. The change in hypothyroidism after steroid therapy was also examined.

RESULTS

Eight patients (10%) had hypothyroidism of 6 patients had subclinical hypothyroidism with a normal serum free thyroxine (FT4) and high thyroid stimulating hormone (TSH) level, and 2 patients had central hypothyroidism with low serum free triiodothyronine (FT3), FT4 and TSH levels. A significant goiter of the thyroid was not observed in any patient. There were no significant differences in age; male to female ratio; serum concentrations of IgG and IgG4-related disease (IgG4-RD); presence of anti-thyroglobulin antibody, antinuclear antigen or rheumatoid factor; or presence of extrapancreatic lesions between the 6 patients with subclinical hypothyroidism and patients with euthyroidism. After steroid therapy, both subclinical and central hypothyroidism improved with improvement of the AIP.

CONCLUSION

Hypothyroidism was observed in 8 (10%) of 77 AIP patients and was subclinical in 6 patients and central in 2 patients. Further studies are necessary to clarify whether this subclinical hypothyroidism is another manifestation of IgG4-RD.

摘要

目的

研究自身免疫性胰腺炎(AIP)患者的甲状腺功能及甲状腺功能减退的临床特征。

方法

我们对77例根据2011年日本AIP诊断标准确诊的1型AIP患者(50例男性,27例女性;中位年龄68岁,范围33 - 85岁)进行了甲状腺功能检查。我们比较了有不同类型甲状腺功能减退和无甲状腺功能减退患者的临床及血清学检查结果。还研究了激素治疗后甲状腺功能减退的变化情况。

结果

8例患者(10%)存在甲状腺功能减退,其中6例为亚临床甲状腺功能减退,血清游离甲状腺素(FT4)正常但促甲状腺激素(TSH)水平升高,2例为中枢性甲状腺功能减退,血清游离三碘甲状腺原氨酸(FT3)、FT4及TSH水平均降低。所有患者均未观察到明显的甲状腺肿大。亚临床甲状腺功能减退的6例患者与甲状腺功能正常的患者在年龄、男女比例、IgG及IgG4相关疾病(IgG4 - RD)的血清浓度、抗甲状腺球蛋白抗体、抗核抗原或类风湿因子的存在情况,或胰腺外病变的存在情况方面均无显著差异。激素治疗后,随着AIP病情的改善,亚临床甲状腺功能减退和中枢性甲状腺功能减退均有所改善。

结论

77例AIP患者中有8例(10%)存在甲状腺功能减退,其中6例为亚临床甲状腺功能减退,2例为中枢性甲状腺功能减退。需要进一步研究以明确这种亚临床甲状腺功能减退是否为IgG4 - RD的另一种表现形式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验